PBMCs: a new source of diagnostic and prognostic biomarkers

Refrences

• Ajit, S.K., 2012. Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors, 12 (3), 3359–3369.
   PubMed Web of Science ®Google Scholar
• Baine, M.J., et al., 2011. Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS One, 6 (2), e17014.
   PubMed Web of Science ®Google Scholar
• Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell, 136 (2), 215–233.
   PubMed Web of Science ®Google Scholar
• Bartels, C.L., and Tsongalis, G.J., 2009. MicroRNAs: novel biomarkers for human cancer. Clinical chemistry, 55 (4), 623–631.
   PubMed Web of Science ®Google Scholar
• Barwari, T., Joshi, A., and Mayr, M., 2016. MicroRNAs in cardiovascular disease. Journal of the American college of cardiology, 68 (23), 2577–2584.
   PubMed Web of Science ®Google Scholar
• Bluth, M., et al., 2008. Use of gene expression profiles in cells of peripheral blood to identify new molecular markers of acute pancreatitis. Archives of surgery, 143 (3), 227–233.
   PubMedGoogle Scholar
• Bronkhorst, A.J., Ungerer, V., and Holdenrieder, S., 2019. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomolecular detection and quantification, 17, 100087.
   PubMedGoogle Scholar
• Burczynski, M.E., et al., 2005. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clinical cancer research: an official journal of the American association for cancer research, 11 (3), 1181–1189.
   PubMed Web of Science ®Google Scholar
• Chang, Y., et al., 2017. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. Therapeutics and clinical risk management, 13, 1363–1374.
   PubMed Web of Science ®Google Scholar
• Chen, K.-D., et al., 2011. Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer’s disease. Neurobiology of disease, 43 (3), 698–705.
   PubMed Web of Science ®Google Scholar
• Chen, X., et al., 2008. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell research, 18 (10), 997–1006.
   PubMed Web of Science ®Google Scholar
• Corral-Fernández, N., et al., 2013. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes. Experimental and clinical endocrinology & diabetes, 121 (06), 347–353.
   PubMedGoogle Scholar
• Edwards, C.J., et al., 2007. Molecular profile of peripheral blood mononuclear cells from patients with rheumatoid arthritis. Molecular medicine, 13 (1–2), 40–58.
   PubMed Web of Science ®Google Scholar
• Gavin, D.P., and Sharma, R.P., 2009. Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. Cardiovascular psychiatry and neurology, 2009, 1–4.
   Google Scholar
• Gilad, S., et al., 2008. Serum microRNAs are promising novel biomarkers. PLoS One, 3 (9), e3148.
   PubMed Web of Science ®Google Scholar
• Gupta, S.K., Bang, C., and Thum, T., 2010. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circulation: cardiovascular genetics, 3 (5), 484–488.
   PubMed Web of Science ®Google Scholar
• Han, Y., et al., 2017. LINE-1 methylation in peripheral blood leukocytes and clinical characteristics and prognosis of prostate cancer patients. Oncotarget, 8 (55), 94020.
   PubMedGoogle Scholar
• Hartwell, L., et al., 2006. Cancer biomarkers: a systems approach. Nature biotechnology, 24 (8), 905–908.
   PubMed Web of Science ®Google Scholar
• Hayes, J., Peruzzi, P.P., and Lawler, S., 2014. MicroRNAs in cancer: biomarkers, functions and therapy. Trends in molecular medicine, 20 (8), 460–469.
   PubMed Web of Science ®Google Scholar
• Herman, J.G., ed., 1999. Hypermethylation of tumor suppressor genes in cancer. Seminars in cancer biology, 9 (5), 359–367.
   PubMed Web of Science ®Google Scholar
• Hoekstra, M., et al., 2010. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochemical and biophysical research communications, 394 (3), 792–797.
   PubMed Web of Science ®Google Scholar
• Huang, H., et al., 2010. Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. The American journal of gastroenterology, 105 (7), 1661–1669.
   PubMed Web of Science ®Google Scholar
• Ishizone, S., et al., 2006. Clinical utility of quantitative RT‐PCR targeted to α1, 4‐N‐acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. Cancer science, 97 (2), 119–126.
   PubMed Web of Science ®Google Scholar
• Kaur, S., et al., 2012. Early diagnosis of pancreatic cancer: challenges and new developments. Biomarkers in medicine, 6 (5), 597–612.
   PubMed Web of Science ®Google Scholar
• Kazazian, H.H., and Moran, J.V., 1998. The impact of L1 retrotransposons on the human genome. Nature Genetics, 19 (1), 19–24.
   PubMed Web of Science ®Google Scholar
• Kim, B-H., et al., 2009. CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma. Virchows Archiv, 455 (4), 343–351.
   PubMed Web of Science ®Google Scholar
• Kitkumthorn, N., et al., 2012. LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients. Clinica chimica acta, 413 (9–10), 869–874.
   PubMed Web of Science ®Google Scholar
• Kongruttanachok, N., et al., 2010. Replication independent DNA double-strand break retention may prevent genomic instability. Molecular cancer, 9 (1), 70.
   PubMedGoogle Scholar
• Ludwig, J.A., and Weinstein, J.N., 2005. Biomarkers in cancer staging, prognosis and treatment selection. Nature reviews cancer, 5 (11), 845–856.
   PubMed Web of Science ®Google Scholar
• Ma, J., et al., 2015. Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer. Laboratory investigation, 95 (10), 1197–1206.
   PubMed Web of Science ®Google Scholar
• Ma, Z., et al., 2013. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study. Journal of cancer research and clinical oncology, 139 (4), 557–562.
   PubMed Web of Science ®Google Scholar
• Milagro, F.I., et al., 2013. High-throughput sequencing of microRNAs in peripheral blood mononuclear cells: identification of potential weight loss biomarkers. PLoS one, 8 (1), e54319.
   PubMed Web of Science ®Google Scholar
• Mishra, S., et al., 2015. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer. Cancer letters, 369 (1), 67–75.
   PubMed Web of Science ®Google Scholar
• Mosallaei, M., and Simonian, M., 2019. MicroRNAs as novel potential biomarker in gastric cancer: diagnostic and prognostic biomarkers. Acta medica iranica, 10, 25–26.
   Google Scholar
• Mosallaei, M., et al., 2018. Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant. Journal of gastrointestinal oncology, 9 (3), 448–457.
   PubMed Web of Science ®Google Scholar
• Nardo, G., et al., 2011. Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells. PLoS one, 6 (10), e25545.
   PubMed Web of Science ®Google Scholar
• Parikh, N.I. and Vasan, R.S., 2007. Assessing the clinical utility of biomarkers in medicine. Biomarkers in medicine, 1, 419–436.
   PubMed Web of Science ®Google Scholar
• Pauley, K.M., et al., 2008. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis research & therapy, 10 (4), R101.
   PubMed Web of Science ®Google Scholar
• Romaine, S.P., et al., 2015. MicroRNAs in cardiovascular disease: an introduction for clinicians. Heart, 101 (12), 921–928.
   PubMed Web of Science ®Google Scholar
• Salehi, R., et al., 2015. Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer. Advanced biomedical research, 4 (1), 252.
   PubMedGoogle Scholar
• Sharma, P., et al., 2005. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast cancer research, 7 (5), R634.
   PubMed Web of Science ®Google Scholar
• Showe, M.K., et al., 2009. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non–small cell lung cancer from patients with nonmalignant lung disease. Cancer research, 69 (24), 9202–9210.
   PubMed Web of Science ®Google Scholar
• Silva, D. C. P. d., et al., 2018. Role of miRNAs on the pathophysiology of cardiovascular diseases. Arquivos Brasileiros de Cardiologia, 111 (5), 738–746.
   PubMed Web of Science ®Google Scholar
• Smiraglia, D.J., and Plass, C., 2002. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene, 21 (35), 5414–5426.
   PubMed Web of Science ®Google Scholar
• Srivastava, S., 2017. Biomarkers in cancer screening and early detection. New York, NY: John Wiley & Sons.
   Google Scholar
• Sun, C.-J., Zhang, L., and Zhang, W.-Y., 2009. Gene expression profiling of maternal blood in early onset severe preeclampsia: identification of novel biomarkers. Journal of perinatal medicine, 37 (6), 609–616.
   PubMed Web of Science ®Google Scholar
• Sun, X-Y., et al., 2015. Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. Journal of clinical neuroscience, 22 (3), 570–574.
   PubMed Web of Science ®Google Scholar
• Thum, T., Catalucci, D., and Bauersachs, J., 2008. MicroRNAs: novel regulators in cardiac development and disease. Cardiovascular research, 79 (4), 562–570.
   PubMed Web of Science ®Google Scholar
• Thum, T., et al., 2007. MicroRNAs in the human heart. Circulation, 116 (3), 258–267.
   PubMed Web of Science ®Google Scholar
• Tie, Y., et al., 2009. Circulating miRNA and cancer diagnosis. Science in China series C: life sciences, 52 (12), 1117–1122.
   PubMedGoogle Scholar
• Twine, N.C., et al., 2003. Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer research, 63 (18), 6069–6075.
   PubMed Web of Science ®Google Scholar
• Ulivi, P., et al., 2013. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. International journal of molecular sciences, 14 (5), 10332–10342.
   PubMed Web of Science ®Google Scholar
• Ultimo, S., et al., 2018. Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise. Oncotarget, 9 (24), 17238.
   PubMedGoogle Scholar
• Vahed, S.Z., et al., 2019. Expression pattern of miR-21, miR-25 and PTEN in peripheral blood mononuclear cells of patients with significant or insignificant coronary stenosis. Gene, 698, 170–178.
   PubMed Web of Science ®Google Scholar
• Vatandoost, N., et al., 2015. Dysregulated miR-103 and miR-143 expression in peripheral blood mononuclear cells from induced prediabetes and type 2 diabetes rats. Gene, 572 (1), 95–100.
   PubMed Web of Science ®Google Scholar
• Voellenkle, C., et al., 2010. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiological genomics, 42 (3), 420–426.
   PubMed Web of Science ®Google Scholar
• Wagner, P.D., Verma, M., and Srivastava, S., 2004. Challenges for biomarkers in cancer detection. Annals of the New York academy of sciences, 1022 (1), 9–16.
   PubMedGoogle Scholar
• Whitney, A.R., et al., 2003. Individuality and variation in gene expression patterns in human blood. Proceedings of the national academy of sciences, 100 (4), 1896–1901.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., and Ji, X., 2014. First trimester PBMC microRNA predicts adverse pregnancy outcome. American journal of reproductive immunology, 72 (5), 515–526.
   PubMed Web of Science ®Google Scholar
• Xu, J., et al., 2012. Circulating microRNAs: novel biomarkers for cardiovascular diseases. Journal of molecular medicine, 90 (8), 865–875.
   PubMed Web of Science ®Google Scholar
• Xu, S., et al., 2015. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. International journal of clinical and experimental pathology, 8 (11), 14335.
   PubMed Web of Science ®Google Scholar
• Yang, B., et al., 2016. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer. Cancer biomarkers, 17 (2), 223–230.
   PubMed Web of Science ®Google Scholar
• Yang, Y.-L., et al., 2015. Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients. Tumor biology, 36 (9), 7069–7075.
   PubMedGoogle Scholar
• Zeng, X-l., et al., 2013. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer. Chinese medical journal, 126 (23), 4510–4516.
   PubMed Web of Science ®Google Scholar
• Zhuang, Z.-G., et al., 2017. The circular RNA of peripheral blood mononuclear cells: Hsa_circ_0005836 as a new diagnostic biomarker and therapeutic target of active pulmonary tuberculosis. Molecular immunology, 90, 264–272.
   PubMed Web of Science ®Google Scholar